445 related articles for article (PubMed ID: 24140748)
1. Multifunctional nanoparticles for targeted delivery of immune activating and cancer therapeutic agents.
Jia F; Liu X; Li L; Mallapragada S; Narasimhan B; Wang Q
J Control Release; 2013 Dec; 172(3):1020-34. PubMed ID: 24140748
[TBL] [Abstract][Full Text] [Related]
2. Promising approaches in using magnetic nanoparticles in oncology.
Mikhaylov G; Vasiljeva O
Biol Chem; 2011 Nov; 392(11):955-60. PubMed ID: 21848508
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional superparamagnetic iron oxide nanoparticles: promising tools in cancer theranostics.
Santhosh PB; Ulrih NP
Cancer Lett; 2013 Aug; 336(1):8-17. PubMed ID: 23664890
[TBL] [Abstract][Full Text] [Related]
4. Targeting cancer with hyaluronic acid-based nanocarriers: recent advances and translational perspectives.
Cadete A; Alonso MJ
Nanomedicine (Lond); 2016 Sep; 11(17):2341-57. PubMed ID: 27526874
[TBL] [Abstract][Full Text] [Related]
5. Engineered multifunctional nanocarriers for cancer diagnosis and therapeutics.
Shi D; Bedford NM; Cho HS
Small; 2011 Sep; 7(18):2549-67. PubMed ID: 21648074
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous nuclear imaging and intranuclear drug delivery by nuclear-targeted multifunctional upconversion nanoprobes.
Liu JN; Bu W; Pan LM; Zhang S; Chen F; Zhou L; Zhao KL; Peng W; Shi J
Biomaterials; 2012 Oct; 33(29):7282-90. PubMed ID: 22796158
[TBL] [Abstract][Full Text] [Related]
7. Smart multifunctional drug delivery towards anticancer therapy harmonized in mesoporous nanoparticles.
Baek S; Singh RK; Khanal D; Patel KD; Lee EJ; Leong KW; Chrzanowski W; Kim HW
Nanoscale; 2015 Sep; 7(34):14191-216. PubMed ID: 26260245
[TBL] [Abstract][Full Text] [Related]
8. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect.
Acharya S; Sahoo SK
Adv Drug Deliv Rev; 2011 Mar; 63(3):170-83. PubMed ID: 20965219
[TBL] [Abstract][Full Text] [Related]
9. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
10. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
11. Precision Cancer Nanotherapy: Evolving Role of Multifunctional Nanoparticles for Cancer Active Targeting.
Ahmad A; Khan F; Mishra RK; Khan R
J Med Chem; 2019 Dec; 62(23):10475-10496. PubMed ID: 31339714
[TBL] [Abstract][Full Text] [Related]
12. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
13. Self-Monitoring and Self-Delivery of Photosensitizer-Doped Nanoparticles for Highly Effective Combination Cancer Therapy in Vitro and in Vivo.
Zhang J; Liang YC; Lin X; Zhu X; Yan L; Li S; Yang X; Zhu G; Rogach AL; Yu PK; Shi P; Tu LC; Chang CC; Zhang X; Chen X; Zhang W; Lee CS
ACS Nano; 2015 Oct; 9(10):9741-56. PubMed ID: 26390118
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional and multitargeted nanoparticles for drug delivery to overcome barriers of drug resistance in human cancers.
Dawar S; Singh N; Kanwar RK; Kennedy RL; Veedu RN; Zhou SF; Krishnakumar S; Hazra S; Sasidharan S; Duan W; Kanwar JR
Drug Discov Today; 2013 Dec; 18(23-24):1292-300. PubMed ID: 24055842
[TBL] [Abstract][Full Text] [Related]
15. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
[TBL] [Abstract][Full Text] [Related]
16. Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation.
Shi J; Xiao Z; Kamaly N; Farokhzad OC
Acc Chem Res; 2011 Oct; 44(10):1123-34. PubMed ID: 21692448
[TBL] [Abstract][Full Text] [Related]
17. Supramolecular self-assembly forming a multifunctional synergistic system for targeted co-delivery of gene and drug.
Zhao F; Yin H; Li J
Biomaterials; 2014 Jan; 35(3):1050-62. PubMed ID: 24189097
[TBL] [Abstract][Full Text] [Related]
18. Hierarchical targeted hepatocyte mitochondrial multifunctional chitosan nanoparticles for anticancer drug delivery.
Chen Z; Zhang L; Song Y; He J; Wu L; Zhao C; Xiao Y; Li W; Cai B; Cheng H; Li W
Biomaterials; 2015 Jun; 52():240-50. PubMed ID: 25818430
[TBL] [Abstract][Full Text] [Related]
19. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
20. Tumor-homing multifunctional nanoparticles for cancer theragnosis: Simultaneous diagnosis, drug delivery, and therapeutic monitoring.
Kim K; Kim JH; Park H; Kim YS; Park K; Nam H; Lee S; Park JH; Park RW; Kim IS; Choi K; Kim SY; Park K; Kwon IC
J Control Release; 2010 Sep; 146(2):219-27. PubMed ID: 20403397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
